vs
Crinetics Pharmaceuticals, Inc.（CRNX）与Rithm Property Trust Inc.（RPT）财务数据对比。点击上方公司名可切换其他公司
Crinetics Pharmaceuticals, Inc.的季度营收约是Rithm Property Trust Inc.的1.8倍（$6.2M vs $3.4M），Rithm Property Trust Inc.净利率更高（95.4% vs -1993.4%，领先2088.8%）
Crinetics Pharmaceuticals是一家全球化制药企业，由Scott Struthers、Frank Zhu、Ana Kusnetzow、Stephen F. Betz于2008年共同创立，总部位于美国加利福尼亚州圣迭戈，专注于内分泌相关疾病的治疗药物研发，2018年在纳斯达克正式上市。
Rithm Property Trust Inc.旗下的里思资本是一家总部位于纽约的美国投资管理公司，核心业务聚焦于房地产投资及另类投资领域，是该赛道颇具影响力的专业投资机构。
CRNX vs RPT — 直观对比
营收规模更大
CRNX
是对方的1.8倍
$3.4M
净利率更高
RPT
高出2088.8%
-1993.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.2M | $3.4M |
| 净利润 | $-122.8M | $3.2M |
| 毛利率 | — | — |
| 营业利润率 | -2169.6% | 99.6% |
| 净利率 | -1993.4% | 95.4% |
| 营收同比 | — | -39.7% |
| 净利润同比 | -52.4% | 11.2% |
| 每股收益（稀释后） | $-1.30 | $-0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CRNXRPT
| Q4 25 | $6.2M | $3.4M | ||
| Q3 25 | — | $4.0M | ||
| Q2 25 | $1.0M | $4.2M | ||
| Q1 25 | — | $249.0K | ||
| Q4 24 | $0 | — | ||
| Q3 24 | $0 | — | ||
| Q4 23 | $0 | — | ||
| Q3 23 | — | $1.1M |
净利润CRNXRPT
| Q4 25 | $-122.8M | $3.2M | ||
| Q3 25 | — | $-273.0K | ||
| Q2 25 | $-115.6M | $1.9M | ||
| Q1 25 | — | $-3.4M | ||
| Q4 24 | $-80.6M | — | ||
| Q3 24 | $-76.8M | — | ||
| Q4 23 | $-60.1M | — | ||
| Q3 23 | — | $-5.5M |
营业利润率CRNXRPT
| Q4 25 | -2169.6% | 99.6% | ||
| Q3 25 | — | -6.2% | ||
| Q2 25 | -12523.0% | 45.7% | ||
| Q1 25 | — | -1416.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | -533.4% |
净利率CRNXRPT
| Q4 25 | -1993.4% | 95.4% | ||
| Q3 25 | — | -6.8% | ||
| Q2 25 | -11216.0% | 45.1% | ||
| Q1 25 | — | -1363.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | -526.3% |
每股收益（稀释后）CRNXRPT
| Q4 25 | $-1.30 | $-0.26 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | $-1.23 | $0.01 | ||
| Q1 25 | — | $-0.08 | ||
| Q4 24 | $-0.86 | — | ||
| Q3 24 | $-0.96 | — | ||
| Q4 23 | $-0.89 | — | ||
| Q3 23 | — | $-0.25 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.0B | $79.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $992.1M | $291.6M |
| 总资产 | $1.1B | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CRNXRPT
| Q4 25 | $1.0B | $79.3M | ||
| Q3 25 | — | $81.4M | ||
| Q2 25 | $1.2B | $98.6M | ||
| Q1 25 | — | $97.4M | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $862.7M | — | ||
| Q4 23 | $558.6M | — | ||
| Q3 23 | — | $63.9M |
股东权益CRNXRPT
| Q4 25 | $992.1M | $291.6M | ||
| Q3 25 | — | $291.7M | ||
| Q2 25 | $1.2B | $294.7M | ||
| Q1 25 | — | $296.1M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $833.0M | — | ||
| Q4 23 | $539.1M | — | ||
| Q3 23 | — | $320.2M |
总资产CRNXRPT
| Q4 25 | $1.1B | $1.0B | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | $1.3B | $1.0B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $937.4M | — | ||
| Q4 23 | $635.4M | — | ||
| Q3 23 | — | $1.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-92.9M | $-8.3M |
| 自由现金流经营现金流 - 资本支出 | $-93.4M | — |
| 自由现金流率自由现金流/营收 | -1515.3% | — |
| 资本支出强度资本支出/营收 | 7.4% | — |
| 现金转化率经营现金流/净利润 | — | -2.56× |
| 过去12个月自由现金流最近4个季度 | $-311.5M | — |
8季度趋势，按日历期对齐
经营现金流CRNXRPT
| Q4 25 | $-92.9M | $-8.3M | ||
| Q3 25 | — | $-5.8M | ||
| Q2 25 | $-85.9M | $-25.0K | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | $-64.7M | — | ||
| Q3 24 | $-62.8M | — | ||
| Q4 23 | $-40.8M | — | ||
| Q3 23 | — | $-10.7M |
自由现金流CRNXRPT
| Q4 25 | $-93.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-89.1M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-65.7M | — | ||
| Q3 24 | $-63.4M | — | ||
| Q4 23 | $-41.7M | — | ||
| Q3 23 | — | — |
自由现金流率CRNXRPT
| Q4 25 | -1515.3% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -8637.5% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
资本支出强度CRNXRPT
| Q4 25 | 7.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 310.6% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | 0.0% |
现金转化率CRNXRPT
| Q4 25 | — | -2.56× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.01× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CRNX
| Products | $5.4M | 88% |
| Other | $741.0K | 12% |
RPT
暂无分部数据
